{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/NRIX/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-15T17:49:17.852Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":9680,"canonical_name":"Nurix Therapeutics, Inc.","cik":"0001549595","uei":null,"lei":null,"duns":null,"ticker":"NRIX"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":76},"count":76,"timeline":[{"ts":"2026-10-13","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Nurix Therapeutics, Inc. — 2026-10-13","url_slug":"/sec/cik-0001549595/10-q/0001549595-26-000049","accession_number":"0001549595-26-000049","importance":45},{"ts":"2026-10-13","kind":"sec.filing","form_type":"8-K","title":"8-K — Nurix Therapeutics, Inc. — 2026-10-13","url_slug":"/sec/cik-0001549595/8-k/0001549595-26-000048","accession_number":"0001549595-26-000048","importance":35},{"ts":"2026-10-02","kind":"sec.filing","form_type":"144","title":"144 — Nurix Therapeutics, Inc. — 2026-10-02","url_slug":"/sec/cik-0001549595/144/0001950047-26-010001","accession_number":"0001950047-26-010001","importance":30},{"ts":"2026-10-02","kind":"sec.filing","form_type":"4","title":"4 — Nurix Therapeutics, Inc. — 2026-10-02","url_slug":"/sec/cik-0001549595/4/0001817199-26-000032","accession_number":"0001817199-26-000032","importance":30},{"ts":"2026-09-02","kind":"sec.filing","form_type":"144","title":"144 — Nurix Therapeutics, Inc. — 2026-09-02","url_slug":"/sec/cik-0001549595/144/0001950047-26-009016","accession_number":"0001950047-26-009016","importance":30},{"ts":"2026-09-02","kind":"sec.filing","form_type":"4","title":"4 — Nurix Therapeutics, Inc. — 2026-09-02","url_slug":"/sec/cik-0001549595/4/0001817199-26-000030","accession_number":"0001817199-26-000030","importance":30},{"ts":"2026-09-01","kind":"sec.filing","form_type":"4","title":"4 — Nurix Therapeutics, Inc. — 2026-09-01","url_slug":"/sec/cik-0001549595/4/0001817160-26-000019","accession_number":"0001817160-26-000019","importance":30},{"ts":"2026-08-14","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — Nurix Therapeutics, Inc. — 2026-08-14","url_slug":"/sec/cik-0001549595/schedule-13g/0000080255-26-000570","accession_number":"0000080255-26-000570","importance":55},{"ts":"2026-08-14","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — Nurix Therapeutics, Inc. — 2026-08-14","url_slug":"/sec/cik-0001549595/schedule-13g/0001104659-26-097100","accession_number":"0001104659-26-097100","importance":55},{"ts":"2026-08-14","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Nurix Therapeutics, Inc. — 2026-08-14","url_slug":"/sec/cik-0001549595/schedule-13g-a/0000902664-26-003499","accession_number":"0000902664-26-003499","importance":30},{"ts":"2026-08-14","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Nurix Therapeutics, Inc. — 2026-08-14","url_slug":"/sec/cik-0001549595/schedule-13g-a/0001172661-26-003488","accession_number":"0001172661-26-003488","importance":30},{"ts":"2026-08-05","kind":"sec.insider.s","reporter":"Hansen Gwenn","title":"Chief Scientific Officer","shares":4356,"price_per_share":25,"usd_value":108900,"security_title":"Common Stock","importance":35.1089},{"ts":"2026-08-05","kind":"sec.filing","form_type":"144","title":"144 — Nurix Therapeutics, Inc. — 2026-08-05","url_slug":"/sec/cik-0001549595/144/0001950047-26-007704","accession_number":"0001950047-26-007704","importance":30},{"ts":"2026-08-05","kind":"sec.filing","form_type":"4","title":"4 — Nurix Therapeutics, Inc. — 2026-08-05","url_slug":"/sec/cik-0001549595/4/0001817160-26-000015","accession_number":"0001817160-26-000015","importance":30},{"ts":"2026-08-05","kind":"sec.filing","form_type":"4","title":"4 — Nurix Therapeutics, Inc. — 2026-08-05","url_slug":"/sec/cik-0001549595/4/0001817160-26-000017","accession_number":"0001817160-26-000017","importance":30},{"ts":"2026-08-05","kind":"sec.insider.m","reporter":"Hansen Gwenn","title":"Chief Scientific Officer","shares":4356,"price_per_share":1.86,"usd_value":8102,"security_title":"Common Stock","importance":15.00810216},{"ts":"2026-08-04","kind":"sec.insider.s","reporter":"van Houte Hans","title":"Chief Financial Officer","shares":2967,"price_per_share":24.6474,"usd_value":73129,"security_title":"Common Stock","importance":35.0731288358},{"ts":"2026-08-04","kind":"sec.insider.s","reporter":"Hansen Gwenn","title":"Chief Scientific Officer","shares":2611,"price_per_share":24.6415,"usd_value":64339,"security_title":"Common Stock","importance":35.0643389565},{"ts":"2026-08-04","kind":"sec.insider.s","reporter":"van Houte Hans","title":"Chief Financial Officer","shares":1794,"price_per_share":23.8911,"usd_value":42861,"security_title":"Common Stock","importance":35.0428606334},{"ts":"2026-08-04","kind":"sec.insider.s","reporter":"Hansen Gwenn","title":"Chief Scientific Officer","shares":1500,"price_per_share":23.8684,"usd_value":35803,"security_title":"Common Stock","importance":35.0358026},{"ts":"2026-08-04","kind":"sec.filing","form_type":"144","title":"144 — Nurix Therapeutics, Inc. — 2026-08-04","url_slug":"/sec/cik-0001549595/144/0001950047-26-007637","accession_number":"0001950047-26-007637","importance":30},{"ts":"2026-08-04","kind":"sec.filing","form_type":"144","title":"144 — Nurix Therapeutics, Inc. — 2026-08-04","url_slug":"/sec/cik-0001549595/144/0001950047-26-007639","accession_number":"0001950047-26-007639","importance":30},{"ts":"2026-08-04","kind":"sec.filing","form_type":"4","title":"4 — Nurix Therapeutics, Inc. — 2026-08-04","url_slug":"/sec/cik-0001549595/4/0001817217-26-000012","accession_number":"0001817217-26-000012","importance":30},{"ts":"2026-08-03","kind":"sec.insider.s","reporter":"Ring Christine","title":"Chief Legal Officer","shares":16589,"price_per_share":23.0489,"usd_value":382358,"security_title":"Common Stock","importance":35.3823582021},{"ts":"2026-08-03","kind":"sec.filing","form_type":"144","title":"144 — Nurix Therapeutics, Inc. — 2026-08-03","url_slug":"/sec/cik-0001549595/144/0001950047-26-007550","accession_number":"0001950047-26-007550","importance":30},{"ts":"2026-08-03","kind":"sec.filing","form_type":"4","title":"4 — Nurix Therapeutics, Inc. — 2026-08-03","url_slug":"/sec/cik-0001549595/4/0001817199-26-000028","accession_number":"0001817199-26-000028","importance":30},{"ts":"2026-08-03","kind":"sec.insider.m","reporter":"Ring Christine","title":"Chief Legal Officer","shares":5787,"price_per_share":8.72,"usd_value":50463,"security_title":"Common Stock","importance":15.05046264},{"ts":"2026-07-31","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — Nurix Therapeutics, Inc. — 2026-07-31","url_slug":"/sec/cik-0001549595/schedule-13g/0002100119-26-001437","accession_number":"0002100119-26-001437","importance":55},{"ts":"2026-07-30","kind":"sec.insider.s","reporter":"Hansen Gwenn","title":"Chief Scientific Officer","shares":3847,"price_per_share":23.3828,"usd_value":89954,"security_title":"Common Stock","importance":35.0899536316},{"ts":"2026-07-30","kind":"sec.insider.s","reporter":"Ring Christine","title":"Chief Legal Officer","shares":3847,"price_per_share":23.3828,"usd_value":89954,"security_title":"Common Stock","importance":35.0899536316},{"ts":"2026-07-30","kind":"sec.insider.s","reporter":"van Houte Hans","title":"Chief Financial Officer","shares":2845,"price_per_share":23.3828,"usd_value":66524,"security_title":"Common Stock","importance":35.066524066},{"ts":"2026-07-30","kind":"sec.filing","form_type":"4","title":"4 — Nurix Therapeutics, Inc. — 2026-07-30","url_slug":"/sec/cik-0001549595/4/0001817160-26-000012","accession_number":"0001817160-26-000012","importance":30},{"ts":"2026-07-30","kind":"sec.filing","form_type":"4","title":"4 — Nurix Therapeutics, Inc. — 2026-07-30","url_slug":"/sec/cik-0001549595/4/0001817199-26-000026","accession_number":"0001817199-26-000026","importance":30},{"ts":"2026-07-30","kind":"sec.filing","form_type":"4","title":"4 — Nurix Therapeutics, Inc. — 2026-07-30","url_slug":"/sec/cik-0001549595/4/0001817217-26-000010","accession_number":"0001817217-26-000010","importance":30},{"ts":"2026-07-30","kind":"sec.insider.m","reporter":"Hansen Gwenn","title":"Chief Scientific Officer","shares":3750,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-07-30","kind":"sec.insider.m","reporter":"Hansen Gwenn","title":"Chief Scientific Officer","shares":2858,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-07-30","kind":"sec.insider.m","reporter":"Hansen Gwenn","title":"Chief Scientific Officer","shares":3572,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-07-30","kind":"sec.insider.m","reporter":"van Houte Hans","title":"Chief Financial Officer","shares":3750,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-07-30","kind":"sec.insider.m","reporter":"van Houte Hans","title":"Chief Financial Officer","shares":2858,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-07-30","kind":"sec.insider.m","reporter":"van Houte Hans","title":"Chief Financial Officer","shares":3572,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-07-30","kind":"sec.insider.m","reporter":"Ring Christine","title":"Chief Legal Officer","shares":3750,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-07-30","kind":"sec.insider.m","reporter":"Ring Christine","title":"Chief Legal Officer","shares":2858,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-07-30","kind":"sec.insider.m","reporter":"Ring Christine","title":"Chief Legal Officer","shares":3572,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-07-09","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Nurix Therapeutics, Inc. — 2026-07-09","url_slug":"/sec/cik-0001549595/10-q/0001549595-26-000040","accession_number":"0001549595-26-000040","importance":45},{"ts":"2026-07-09","kind":"sec.filing","form_type":"8-K","title":"8-K — Nurix Therapeutics, Inc. — 2026-07-09","url_slug":"/sec/cik-0001549595/8-k/0001549595-26-000038","accession_number":"0001549595-26-000038","importance":35},{"ts":"2026-07-02","kind":"sec.form144","reporter":"CHRISTINE RING","title":"Officer","shares":11008,"usd_value":263201,"security_title":"Common","approx_sale_date":"2026-07-02","accession_number":"0001950047-26-006819","importance":40.052640256},{"ts":"2026-07-02","kind":"sec.insider.s","reporter":"Ring Christine","title":"Chief Legal Officer","shares":11008,"price_per_share":23.5616,"usd_value":259366,"security_title":"Common Stock","importance":35.2593660928},{"ts":"2026-07-02","kind":"sec.filing","form_type":"144","title":"144 — Nurix Therapeutics, Inc. — 2026-07-02","url_slug":"/sec/cik-0001549595/144/0001950047-26-006819","accession_number":"0001950047-26-006819","importance":30},{"ts":"2026-07-02","kind":"sec.filing","form_type":"4","title":"4 — Nurix Therapeutics, Inc. — 2026-07-02","url_slug":"/sec/cik-0001549595/4/0001817199-26-000024","accession_number":"0001817199-26-000024","importance":30},{"ts":"2026-07-02","kind":"sec.insider.m","reporter":"Ring Christine","title":"Chief Legal Officer","shares":5787,"price_per_share":8.72,"usd_value":50463,"security_title":"Common Stock","importance":15.05046264},{"ts":"2026-07-02","kind":"sec.insider.m","reporter":"Ring Christine","title":"Chief Legal Officer","shares":5221,"price_per_share":1.86,"usd_value":9711,"security_title":"Common Stock","importance":15.00971106},{"ts":"2026-06-25","kind":"sec.form144","reporter":"CHRISTINE RING","title":"Officer","shares":28935,"usd_value":558446,"security_title":"Common","approx_sale_date":"2026-06-25","accession_number":"0001950047-26-006501","importance":40.1116891},{"ts":"2026-06-25","kind":"sec.form144","reporter":"GWENN M HANSEN","title":"Officer","shares":5394,"usd_value":104104,"security_title":"Common","approx_sale_date":"2026-06-25","accession_number":"0001950047-26-006499","importance":40.02082084},{"ts":"2026-06-25","kind":"sec.insider.s","reporter":"Ring Christine","title":"Chief Legal Officer","shares":28935,"price_per_share":20.0624,"usd_value":580506,"security_title":"Common Stock","importance":35.580505544},{"ts":"2026-06-25","kind":"sec.insider.s","reporter":"Hansen Gwenn","title":"Chief Scientific Officer","shares":5394,"price_per_share":20,"usd_value":107880,"security_title":"Common Stock","importance":35.10788},{"ts":"2026-06-25","kind":"sec.filing","form_type":"144","title":"144 — Nurix Therapeutics, Inc. — 2026-06-25","url_slug":"/sec/cik-0001549595/144/0001950047-26-006499","accession_number":"0001950047-26-006499","importance":30},{"ts":"2026-06-25","kind":"sec.filing","form_type":"144","title":"144 — Nurix Therapeutics, Inc. — 2026-06-25","url_slug":"/sec/cik-0001549595/144/0001950047-26-006501","accession_number":"0001950047-26-006501","importance":30},{"ts":"2026-06-25","kind":"sec.filing","form_type":"4","title":"4 — Nurix Therapeutics, Inc. — 2026-06-25","url_slug":"/sec/cik-0001549595/4/0001817160-26-000010","accession_number":"0001817160-26-000010","importance":30},{"ts":"2026-06-25","kind":"sec.filing","form_type":"4","title":"4 — Nurix Therapeutics, Inc. — 2026-06-25","url_slug":"/sec/cik-0001549595/4/0001817199-26-000022","accession_number":"0001817199-26-000022","importance":30},{"ts":"2026-06-25","kind":"sec.insider.m","reporter":"Ring Christine","title":"Chief Legal Officer","shares":15602,"price_per_share":8.72,"usd_value":136049,"security_title":"Common Stock","importance":15.13604944},{"ts":"2026-06-25","kind":"sec.insider.m","reporter":"Ring Christine","title":"Chief Legal Officer","shares":13333,"price_per_share":7.26,"usd_value":96798,"security_title":"Common Stock","importance":15.09679758},{"ts":"2026-06-11","kind":"sec.filing","form_type":"8-K","title":"8-K — Nurix Therapeutics, Inc. — 2026-06-11","url_slug":"/sec/cik-0001549595/8-k/0001549595-26-000034","accession_number":"0001549595-26-000034","importance":35},{"ts":"2026-06-08","kind":"sec.filing","form_type":"8-K","title":"8-K — Nurix Therapeutics, Inc. — 2026-06-08","url_slug":"/sec/cik-0001549595/8-k/0001549595-26-000030","accession_number":"0001549595-26-000030","importance":35},{"ts":"2026-06-02","kind":"sec.form144","reporter":"CHRISTINE RING","title":"Officer","shares":8148,"usd_value":141694,"security_title":"Common","approx_sale_date":"2026-06-02","accession_number":"0001950047-26-005496","importance":40.028338744},{"ts":"2026-06-02","kind":"sec.insider.s","reporter":"Ring Christine","title":"Chief Legal Officer","shares":8148,"price_per_share":16.5995,"usd_value":135253,"security_title":"Common Stock","importance":35.135252726},{"ts":"2026-06-02","kind":"sec.filing","form_type":"144","title":"144 — Nurix Therapeutics, Inc. — 2026-06-02","url_slug":"/sec/cik-0001549595/144/0001950047-26-005496","accession_number":"0001950047-26-005496","importance":30},{"ts":"2026-06-02","kind":"sec.filing","form_type":"4","title":"4 — Nurix Therapeutics, Inc. — 2026-06-02","url_slug":"/sec/cik-0001549595/4/0001817199-26-000020","accession_number":"0001817199-26-000020","importance":30},{"ts":"2026-06-02","kind":"sec.insider.m","reporter":"Ring Christine","title":"Chief Legal Officer","shares":3422,"price_per_share":1.86,"usd_value":6365,"security_title":"Common Stock","importance":15.00636492},{"ts":"2026-05-15","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — Nurix Therapeutics, Inc. — 2026-05-15","url_slug":"/sec/cik-0001549595/schedule-13g/0000902664-26-002545","accession_number":"0000902664-26-002545","importance":55},{"ts":"2026-05-15","kind":"sec.filing","form_type":"8-K","title":"8-K — Nurix Therapeutics, Inc. — 2026-05-15","url_slug":"/sec/cik-0001549595/8-k/0001549595-26-000028","accession_number":"0001549595-26-000028","importance":35},{"ts":"2026-05-15","kind":"sec.filing","form_type":"4","title":"4 — Nurix Therapeutics, Inc. — 2026-05-15","url_slug":"/sec/cik-0001549595/4/0001680739-26-000010","accession_number":"0001680739-26-000010","importance":30},{"ts":"2026-05-15","kind":"sec.filing","form_type":"4","title":"4 — Nurix Therapeutics, Inc. — 2026-05-15","url_slug":"/sec/cik-0001549595/4/0001730703-26-000002","accession_number":"0001730703-26-000002","importance":30},{"ts":"2026-05-15","kind":"sec.filing","form_type":"4","title":"4 — Nurix Therapeutics, Inc. — 2026-05-15","url_slug":"/sec/cik-0001549595/4/0001734422-26-000002","accession_number":"0001734422-26-000002","importance":30},{"ts":"2026-05-15","kind":"sec.filing","form_type":"4","title":"4 — Nurix Therapeutics, Inc. — 2026-05-15","url_slug":"/sec/cik-0001549595/4/0001741836-26-000004","accession_number":"0001741836-26-000004","importance":30},{"ts":"2026-05-15","kind":"sec.filing","form_type":"4","title":"4 — Nurix Therapeutics, Inc. — 2026-05-15","url_slug":"/sec/cik-0001549595/4/0001946233-26-000002","accession_number":"0001946233-26-000002","importance":30},{"ts":"2026-05-15","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Nurix Therapeutics, Inc. — 2026-05-15","url_slug":"/sec/cik-0001549595/schedule-13g-a/0001172661-26-002030","accession_number":"0001172661-26-002030","importance":30}]}